Status:

COMPLETED

Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study)

Lead Sponsor:

CCTU- Cancer Theme

Collaborating Sponsors:

Cambridge University Hospitals NHS Foundation Trust

Cancer Research UK

Conditions:

High Grade Glioma

Eligibility:

All Genders

16+ years

Brief Summary

Brain tumours are the leading cause of cancer deaths in children, men under the age of 45 and women under the age of 25. Glioblastoma is the most common and most malignant primary tumour. The predomin...

Detailed Description

This is a multicentre, prospective longitudinal observational cohort study in patients with high grade glioma, who have surgery planned to remove \>90% of the tumour, and subsequent radical radiothera...

Eligibility Criteria

Inclusion

  • Have given written informed consent to participate
  • Assessed by a neuroscience MDT to have a high grade glioma on imaging, OR if in the opinion of the CI, with guidance from the local PI that all relevant and appropriate members of a multidisciplinary team agree a high grade glioma diagnosis;
  • Considered suitable for radical radiotherapy (60 Gy) with concomitant chemotherapy (Stupp Regime);
  • WHO PS 0 or 1 (see Appendix 3);
  • Age ≥16;
  • Patient suitable for tumour resection where the treating neurosurgeon feels that \>90% of the enhancing tumour will be resected;

Exclusion

  • Patients who are participating in trials involving investigational treatments
  • Patients who are unsuitable for a contrast-enhanced MRI will be excluded. Such clinical problems include, but are not limited to:
  • MR unsafe metallic implants;
  • Claustrophobia;
  • Allergy to gadolinium contrast agent;
  • History of severe renal impairment.
  • Patients unable to provide written informed consent
  • PET sub-study only: Pregnant women

Key Trial Info

Start Date :

March 2 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 11 2024

Estimated Enrollment :

147 Patients enrolled

Trial Details

Trial ID

NCT03294434

Start Date

March 2 2017

End Date

July 11 2024

Last Update

September 27 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cambridge University Hospitals NHS Foundation Trust

Cambridge, United Kingdom, CB2 0QQ

Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study) | DecenTrialz